Second-Generation (Atypical) Antipsychotics and Metabolic Effects

2005/01/01 by John W. Newcomer · 7 citations
Medicine · #Diabetes Treatment and Management #Parkinson's Disease Mechanisms and Treatments #Schizophrenia research and treatment

paper · doi:10.2165/00023210-200519001-00001

crossref issued 2005/01/01 · crossref published 2005/01/01 · crossref published-print 2005/01/01 · openalex publication_date 2005/01/01 · crossref created 2006/01/20 · openalex created_date 2016/06/24 · crossref deposited 2023/05/06 · crossref indexed 2026/07/28 · openalex updated_date 2026/07/29

Citations

• Body Mass Index and the Prevalence of Hypertension and Dyslipidemia

Cited by

• 国外农药噻虫啉（Thiacloprid）—一种新面施用杀虫剂
• Alterations to Melanocortinergic, GABAergic and Cannabinoid Neurotransmission Associated with Olanzapine-Induced Weight Gain
• From Clinical Research to Clinical Practice: A 4-Year Review of Ziprasidone
• Influence of antipsychotics on mortality in schizophrenia: Systematic review
• Principles of Antipsychotic Prescribing for Policy Makers, Circa 2008. Translating Knowledge to Promote Individualized Treatment
• A Literature Review of Quetiapine for Generalized Anxiety Disorder
• Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo‐controlled trials
• Serious mental illness [wikipedia]